Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSIGHTT: SRP-1005 in Huntington's Disease
NCT07536061Phase 1Recruiting
- Sponsor
- Sarepta Therapeutics
- Start
- May 2026
- Primary completion
- Nov 2027
- Countries
- 4
01
Overview
Phase 1 trial of SRP-1005 in Huntington's disease (HD), sponsored by Sarepta Therapeutics. Started May 2026; status: recruiting.
02
Drugs
SRP-1005
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT07536061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07536061.